Cancer
Conditions
Keywords
Cancer Care
Brief summary
The purpose of this research study is to address the challenge of symptom management for hospitalized patients with cancer.
Detailed description
Patients with cancer may experience a considerable symptom burden, often requiring hospitalizations for symptom management. This study will pilot test an electronic symptom monitoring intervention, Improving Management of Patient-Reported Outcomes Via Electronic Data (IMPROVED), versus usual care in hospitalized patients with cancer. The goal of this study is test a model where patients' symptoms are monitored during their hospital admission electronically via tablet computers. The investigators are studying whether patients whose clinicians receive their patients' detailed symptom reports each day have improved symptom management compared to those whose clinicians do not receive their patients' detailed symptom reports each day. The study takes place at Massachusetts General Hospital and involves participating in a study for as long as the participants are admitted to the hospital. The information the investigators collect will help them determine if electronic symptom monitoring improves the care of patients with cancer.
Interventions
OTHERIMPROVED
The electronic symptom monitoring intervention, Improving Management of Patient-Reported Outcomes Via Electronic Data (IMPROVED), consists of patients self-reporting their symptoms each day using a tablet computer. At morning rounds each day, the clinical team will view reports detailing their patients' symptom burden.
OTHERUsual Care
Participants receiving usual care will also self-report their symptoms each day using tablet computers. However, these patients' clinicians will not receive their symptom reports. Patients randomized to usual care will report their symptoms to their clinicians as they usually would, at their own discretion.
Sponsors
Massachusetts General Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age 18 or older * Diagnosed with incurable cancer (defined as receiving treatment with palliative intent as per chemotherapy order entry designation, trial consent forms, or not receiving chemotherapy but followed for incurable disease as per oncology clinic notes) * Admitted to Lunder at Massachusetts General Hospital * Verbal fluency in English
Exclusion criteria
* Unwilling or unable to participate in the study * Admitted electively * Participated during a previous admission
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Rates of participant completion of >2 symptom reports | 2 years | To determine rates of participant completion of \>2 symptom reports, the investigators will assess the proportion of enrolled participants who complete of \>2 symptom reports. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Rates Of Clinicians Developing An Action Plan In Response To Their Patients' Symptom Reports | 2 years | To determine rates of clinicians developing an action plan in response to the symptom reports, the investigators will assess the proportion of clinicians who develop an action plan in response to their patients' symptom reports. |
| Rates Of Clinicians Discussing Their Patients' Symptom Reports | 2 years | To determine rates of clinicians discussing the symptom reports, the investigators will assess the proportion of clinicians who discuss their patients' symptom reports. |
| Change In Patients' Symptom Scores | 2 years | The investigators will compare change in patients' symptom scores from baseline to discharge (using the Edmonton Symptom Assessment System \[ESAS\] symptom scores measured continuously) between study arms. |
| Change In Patients' Psychological Distress | 2 years | The investigators will compare change in patients' psychological distress from baseline to discharge (using the Patient Health Questionnaire-4 \[PHQ-4\] measured continuously) between study arms. |
| Change In Patients' Depression Scores | 2 years | The investigators will compare change in patients' depression scores from baseline to discharge (using the depression questions from the Patient Health Questionnaire-4 \[PHQ-4\] measured continuously) between study arms. |
| Change In Patients' Anxiety Scores | 2 years | The investigators will compare change in patients' anxiety scores from baseline to discharge (using the anxiety questions from the Patient Health Questionnaire-4 \[PHQ-4\] measured continuously) between study arms. |
| Rates Of Clinicians Noting Their Patients' Symptom Reports | 2 years | To determine rates of clinicians noting the symptom reports, the investigators will assess the proportion of clinicians who note their patients' symptom reports. |
| Rates Of Depression Symptoms | 2 years | The investigators will compare rates of depression symptoms (defined as a score of 3 or greater on the depression subscale of the PHQ-4) for each day of hospital admission between study arms. |
| Rates Of Anxiety Symptoms | 2 years | The investigators will compare rates of anxiety symptoms (defined as a score of 3 or greater on the anxiety subscale of the PHQ-4) for each day of hospital admission between study arms. |
| Rates Of Moderate/Severe Psychological Symptoms | 2 years | The investigators will compare rates of psychological symptoms (defined as a score of 6 or greater on the PHQ-4) for each day of hospital admission between study arms. |
| Rates Of Patient Satisfaction | 2 years | The investigators will compare rates of patient satisfaction (defined as patients reporting 'very satisfied' using the FAMCARE) for each day of hospital admission between study arms. |
| Hospital Length Of Stay | 2 years | The investigators will compare hospital length of stay (measured continuously as days admitted to the hospital) between study arms. |
| 30-Day Readmissions Rates | 2 years | The investigators will compare 30-day readmissions rates (defined as a hospital readmission within 30 days of prior hospital discharge) between study arms. |
| Rates Of Moderate/Severe Symptoms | 2 years | The investigators will compare rates of moderate/severe symptoms (defined as ESAS scores ≥4) for each day of hospital admission between study arms. |
Countries
United States
Outcome results
None listed